TABLE 1.
The clinical characteristics in BC with low and high expression of DLGAP5
| Characteristic | Low expression of DLGAP5 | High expression of DLGAP5 | P |
|---|---|---|---|
| n | 204 | 204 | |
| Age, n (%) | 0.618 | ||
| <=70 | 112 (27.5%) | 118 (28.9%) | |
| >70 | 92 (22.5%) | 86 (21.1%) | |
| T stage, n (%) | 0.721 | ||
| T1 | 2 (0.5%) | 1 (0.3%) | |
| T2 | 60 (16%) | 59 (15.8%) | |
| T3 | 96 (25.7%) | 98 (26.2%) | |
| T4 | 33 (8.8%) | 25 (6.7%) | |
| N stage, n (%) | 0.147 | ||
| N0 | 116 (31.7%) | 121 (33.1%) | |
| N1 | 18 (4.9%) | 28 (7.7%) | |
| N2 | 45 (12.3%) | 30 (8.2%) | |
| N3 | 4 (1.1%) | 4 (1.1%) | |
| M stage, n (%) | 0.882 | ||
| M0 | 103 (49.8%) | 93 (44.9%) | |
| M1 | 5 (2.4%) | 6 (2.9%) | |
| Pathologic Stage, n (%) | 0.637 | ||
| Stage I | 2 (0.5%) | 0 (0%) | |
| Stage II | 66 (16.3%) | 64 (15.8%) | |
| Stage III | 67 (16.5%) | 73 (18%) | |
| Stage IV | 68 (16.7%) | 66 (16.3%) | |
| Histologic Grade, n (%) | <0.001 a | ||
| High Grade | 184 (45.4%) | 200 (49.4%) | |
| Low Grade | 19 (4.7%) | 2 (0.5%) | |
| Lymphovascular invasion, n (%) | 0.027 a | ||
| No | 55 (19.6%) | 75 (26.7%) | |
| Yes | 85 (30.2%) | 66 (23.5%) | |
| Smoker, n (%) | 0.385 | ||
| No | 59 (14.9%) | 50 (12.7%) | |
| Yes | 139 (35.2%) | 147 (37.2%) | |
| OS event, n (%) | 0.046 a | ||
| Alive | 125 (30.6%) | 104 (25.5%) | |
| Dead | 79 (19.4%) | 100 (24.5%) | |
| DSS event, n (%) | 0.023 a | ||
| Alive | 149 (37.8%) | 123 (31.2%) | |
| Dead | 51 (12.9%) | 71 (18%) | |
| PFI event, n (%) | 0.036 a | ||
| Alive | 128 (31.4%) | 106 (26%) | |
| Dead | 76 (18.6%) | 98 (24%) |
a
p <0.05.